M&T Bank Corp Acquires 240,400 Shares of Moderna, Inc. $MRNA

M&T Bank Corp significantly increased its stake in Moderna, Inc. by 1,313.8% in Q4, acquiring 240,400 additional shares to hold a total of 258,698 shares valued at $7.63 million. This comes amidst a mixed outlook for Moderna, with positive developments like European approval of its COVID-19/flu combo vaccine and a Phase 3 bird flu vaccine trial, contrasted by a patent infringement lawsuit from CureVac and a consensus “Reduce” rating from analysts. Insider selling by President Stephen Hoge and negative EPS despite beating estimates in the last quarter also contribute to the complex investment picture.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin